Novavax | NVAX - Ação





Ação Alterar Data
Adma Biologics USD 206.46M 9.8M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Geron USD 116.64M 21.21M 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Novartis USD 6.42B 114M 2025-09
Novavax USD 11.54M 1.97M 2025-12
Pfizer USD 11.47B 201M 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
TG Therapeutics USD 125.59M 21.37M 2025-12